Our tumour tissue analyses demonstrated only modest reduction in the number of proliferating tumour cells induced by IFN-α and IL-2, suggesting that immunotherapy reduces tumour size but has only limited effect on intrinsic tumour aggressiveness in vivo. The gene discussed is IFNA1; the disease is neoplasm.